Opdivo

Description

Opdivo
• Skin cancer called melanoma:
“Opdivo” is prescribed in cases where melanoma has spread, or when
it cannot be removed by surgery (common melanoma).
Opdivo is used in combination with Yervoy (Ipilimumab) to treat
patients with widespread or inoperable melanoma (common melanoma).
• Metastatic non-small cell lung cancer in patients
whose disease progressed during or after platinum-based chemotherapy.
• Renal cell carcinoma of the “clear cell” type. “Opdivo”. used
for the treatment of patients with advanced kidney cancer who have previously received
antiangiogenic therapy.
• Classic Hodgkin’s lymphoma (a type of blood cancer in which
lymphocytes (a type of white blood cell) are affected).
Opdivo is used if the cancer has recurred or has spread after
stem cell transplants of spontaneous origin (otologic) and ingestion
a drug called adcetris (Brentuximab vedotin) after a transplant.
Active ingredient: nivolumab

Storage temperature 2-8 degrees

Prescription medicine.